[3]Ren S, Wang J, Ying J, et al. Consensus for HER2 alterations testing in non-small-cell lung cancer[J]. ESMO Open, 2022,7(1):100395. [4]Robichaux J P, Elamin Y Y, Vijayan R, et al. Pan-Cancer Landscape and Analysis o...
【舒格利单抗获ESMO指南非小细胞肺癌双适应症一线治疗推荐】2025年2月10日,基石药业宣布,抗PD-L1单克隆抗体「舒格利单抗」被纳入《欧洲肿瘤内科学会非驱动基因阳性转移性非小细胞肺癌动态临床指南》(ESMO Non-Oncogene-Addicted Metastatic Non-Small-Cell Lung Cancer Living Guideline),同时成为鳞状及非鳞状非小细胞...
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upThe following corrections are made: In the section "Management of advanced/metastatic NSCLC, First-line treatment of EGFR-and ALK-negative NSCLC disease, regardless of PD-L1 status" 1. ...
参考文献: Hendriks LE, Kerr KM, Menis J, Mok TS, et al. ESMO Guidelines Committee. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†. ...
【财华社讯】基石药业-B(02616.HK)公布,公司重磅产品舒格利单抗(择捷美®)被纳入《欧洲肿瘤內科学会非驱动基因阳性转移性非小细胞肺癌动态临床指南》(ESMO NonOncogene-Addicted Metastatic Non-Small-Cell Lung Cancer (NSCLC) Living Guideline) ,同时成为鳞状及非鳞状非小细胞肺癌(鳞状NSCLC及非鳞状NSCLS)双适...
1.Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, Peters S, Planchard D, Smit EF, Solomon BJ, Veronesi G, Reck M; ESMO Guidelines Committee. Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up...
格隆汇2月10日丨基石药业-B(02616.HK)宣布,公司重磅产品舒格利单抗(择捷美®)被纳入《欧洲肿瘤内科学会非驱动基因阳性转移性非小细胞肺癌动态临床指南》(ESMO NonOncogene-Addicted Metastatic Non-Small-Cell Lung Cancer (NSCLC) Living Guideline)("ESMO指南"),同时成为鳞状及非鳞状非小细胞肺癌 (鳞状NSCLC及...
3. Curran WJ, et al. Sequential vs Concurrent Chemoradiation for Stage III Non–Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452–1460. 4. NCCN Clinical Practice Guidelines in Oncology. Non-small cell lung cancer, version 8. 2017 Aug ...
基石药业-B(02616.HK)发布公告,公司重磅产品舒格利单抗(择捷美®)被纳入《欧洲肿瘤内科学会非驱动基因阳性转移性非小细胞肺癌动态临床指南》(ESMO NonOncogene-Addicted Metastatic Non-Small-Cell Lung Cancer (NSCLC) Living Guideline) (ESMO指南),同时成为鳞状及非鳞状非小细胞肺癌 (鳞状NSCLC及非鳞状NSCLS)...
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † Peters S; Adjei AA; Gridelli C;.Metastatic non-smallcell lung cancer (NSCLC):ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up... S Peters,AA Adje...